✦ScienexySCIENCE KNOWLEDGE LIBRARY
topic · SCI-ENG-006-012

Biomaterials and Biomedical Materials

Biomaterials and biomedical materials are natural or engineered materials designed to interact with biological systems for medical, diagnostic, therapeutic, or regenerative purposes. They are used in implants, prostheses, tissue-engineering scaffolds, wound dressings, drug-delivery systems, dental restorations, medical devices, and diagnostic technologies. Their development requires understanding material structure and properties together with cell biology, physiology, immunology, microbiology, chemistry, biomechanics, and clinical requirements.

Engineering stress

Expression

\sigma = \frac{F}{A_0}

Explanation

Engineering stress is the applied axial force divided by the original cross-sectional area. It is useful for describing the mechanical loading of biomaterials and implant specimens during tensile testing.

Conditions

This is the nominal engineering-stress definition. It does not represent the changing true stress after substantial deformation.

Engineering strain

Expression

\varepsilon = \frac{\Delta L}{L_0}

Explanation

Engineering strain is the change in specimen length divided by its original length. It is dimensionless and helps quantify deformation under mechanical loading.

Youngs modulus

Expression

E = \frac{\sigma}{\varepsilon}

Explanation

For a material behaving approximately linearly elastically, Young's modulus is the ratio of engineering stress to engineering strain. It describes stiffness and is important when comparing implants with surrounding tissue.

Conditions

The expression applies within the linear elastic region under appropriate test conditions. Biological tissues are often nonlinear, anisotropic, and time-dependent, so a single constant modulus may not fully describe their behavior.

Degradation rate average

Expression

r = \frac{m_0-m_t}{t}

Explanation

This simple average mass-loss rate estimates how much specimen mass is lost per unit time during a defined degradation test.

Conditions

It is a simplified experimental measure, not a universal kinetic law. It does not distinguish surface erosion from bulk degradation or account for changes in geometry, swelling, or dissolved products.

Contact angle wettability

Expression

\gamma_{SV} = \gamma_{SL} + \gamma_{LV}\cos\theta

Explanation

Young's equation relates the equilibrium contact angle of an ideal liquid droplet on a smooth, chemically homogeneous solid surface to the interfacial energies.

Conditions

The ideal equation assumes a smooth, rigid, chemically homogeneous surface and equilibrium contact. Real biomaterial surfaces may be rough, porous, chemically heterogeneous, or absorbing, so measured contact angles require careful interpretation.

Explanation

1 fundamental concept

Overview

A biomaterial is a material designed to interact with a biological system for a medical purpose. The interaction may involve supporting tissue, replacing a damaged structure, controlling the release of a therapeutic substance, detecting a biological signal, or assisting tissue repair.

Biomaterial and biological material

A biomaterial is not necessarily produced by a living organism. It may be metallic, ceramic, polymeric, composite, or derived from biological sources. A biological material, by contrast, is produced by or is part of a living system, such as collagen, bone, or cellulose. Some biological materials are processed and used as biomaterials.

Biocompatibility

Biocompatibility is the ability of a material or medical device to perform its intended function with an appropriate host response in a specific application. It does not mean that a material is universally harmless or biologically invisible. A material suitable for temporary contact with skin may not be suitable for permanent implantation in blood or bone.

Intended medical function

  • Replace a damaged tissue or anatomical structure.

  • Support or guide tissue regeneration.

  • Deliver drugs or therapeutic molecules at controlled rates.

  • Provide a barrier, seal, coating, or protective surface.

  • Measure, detect, or respond to biological signals.

  • Restore mechanical, electrical, optical, or biochemical functions.

  • Assist diagnosis, surgery, rehabilitation, or long-term patient monitoring.

2 classification of biomaterials

Metals and alloys

Overview

Metallic biomaterials are used when high mechanical strength, toughness, fatigue resistance, or load-bearing capability is required.

Examples

  • Titanium and titanium alloys

  • Cobalt-chromium alloys

  • Medical-grade stainless steels

  • Tantalum and selected magnesium alloys

Applications

  • Orthopedic plates, screws, and joint components

  • Dental implants

  • Bone fixation devices

  • Cardiovascular stents and selected surgical instruments

Advantages

  • High strength and toughness in suitable compositions

  • Good resistance to mechanical fatigue when properly designed

  • Potential for suitable corrosion resistance

  • Established manufacturing and clinical experience for several alloy systems

Limitations

  • Some metallic implants have a much higher elastic modulus than surrounding bone.

  • Corrosion and wear can release ions or particles.

  • Metallic components may cause imaging artifacts in some diagnostic techniques.

  • Mechanical failure can occur through fatigue, fretting, wear, or stress concentration.

Ceramic and glass biomaterials

Overview

Bioceramics and bioactive glasses are inorganic materials used for their hardness, wear resistance, chemical stability, or ability to interact with bone and other tissues.

Examples

  • Alumina

  • Zirconia

  • Hydroxyapatite

  • Tricalcium phosphate

  • Bioactive silicate glasses

Applications

  • Dental crowns and restorations

  • Orthopedic bearing surfaces

  • Bone graft substitutes and coatings

  • Porous structures for bone regeneration

Advantages

  • Excellent hardness and wear resistance in suitable systems

  • Good chemical stability for selected compositions

  • Some compositions can bond chemically with bone or support bone formation

  • Useful surface and biological characteristics in specific applications

Limitations

  • Many ceramics have low fracture toughness compared with metals.

  • Brittle fracture can occur under tensile stress or impact.

  • Manufacturing defects and surface flaws can strongly influence strength.

  • Some bioactive compositions dissolve too rapidly or too slowly for their intended function.

Polymeric biomaterials

Overview

Polymeric biomaterials are macromolecular materials that can be designed with a wide range of flexibility, elasticity, permeability, degradation rates, and surface characteristics.

Examples

  • Polyethylene used in selected joint-bearing components

  • Polyurethane used in certain flexible medical devices

  • Polylactic acid and polyglycolic acid in biodegradable systems

  • Silicone elastomers in selected medical applications

  • Hydrogels used in wound care and tissue engineering

Applications

  • Sutures and wound dressings

  • Catheters and flexible tubing

  • Drug-delivery systems

  • Contact lenses

  • Tissue-engineering scaffolds

  • Selected prosthetic and implant components

Advantages

  • Wide range of mechanical and chemical properties

  • Potential for flexible, lightweight, and complex geometries

  • Some polymers can biodegrade under controlled biological conditions.

  • Surface chemistry and degradation can be tailored for specific uses.

Limitations

  • Some polymers undergo creep, fatigue, swelling, or chemical degradation.

  • Degradation products must be biologically acceptable.

  • Long-term oxidation or environmental stress can alter mechanical performance.

  • Sterilization can change molecular structure and material properties.

Natural and biologically derived materials

Overview

Natural biomaterials are derived from biological sources or use molecules and structures found in living systems. Their biological recognition and degradation behavior can be valuable, but composition and processing variability must be controlled.

Examples

  • Collagen

  • Gelatin

  • Chitosan

  • Alginate

  • Hyaluronic acid

  • Silk fibroin

  • Cellulose-based materials

Applications

  • Wound dressings

  • Tissue-engineering scaffolds

  • Drug-delivery carriers

  • Cell culture matrices

  • Regenerative medicine research

Limitations

  • Natural-source materials may vary between batches.

  • Potential immune responses depend on source, purity, processing, and residual biological components.

  • Mechanical strength and long-term stability may be limited.

  • Sterilization and storage can alter biological activity.

Composite biomaterials

Overview

Composite biomaterials combine two or more material phases to achieve a combination of mechanical, chemical, biological, or degradation characteristics.

Examples

  • Polymer-hydroxyapatite composites

  • Fiber-reinforced polymer medical components

  • Metal implants with bioactive surface coatings

  • Porous ceramic-polymer structures

Design objective

A composite may combine the toughness of a polymer with the bone-related bioactivity of a ceramic, or combine the structural support of a metal with a surface designed to improve tissue interaction.

Limitations

Differences in stiffness, thermal expansion, degradation, and interfacial bonding can cause delamination, particle release, or nonuniform mechanical behavior.

Hydrogels

Definition

Hydrogels are three-dimensional networks of hydrophilic polymer chains that absorb and retain substantial quantities of water while maintaining a network structure.

Properties

  • High water content

  • Soft and tissue-like mechanical behavior in many formulations

  • Potential for controlled diffusion of dissolved substances

  • Adjustable swelling and degradation

  • Potential compatibility with cells in appropriately designed systems

Applications

  • Wound dressings

  • Cell encapsulation

  • Drug delivery

  • Soft tissue engineering

  • Contact lenses

3 biological environment and host response

Overview

When a biomaterial contacts the body, biological molecules, fluids, cells, and tissues interact with its surface and released components. The response depends on the material's composition, surface properties, geometry, location, duration of exposure, and the patient's biological condition.

Protein adsorption

Proteins from blood and tissue fluids often adsorb onto a material surface soon after contact. The identity, amount, orientation, and conformation of adsorbed proteins can influence cell attachment, immune recognition, coagulation, and subsequent tissue responses.

Cell material interactions

Cell adhesion

Cells may attach to material surfaces through proteins and receptors. Surface chemistry, roughness, wettability, and mechanical characteristics influence adhesion.

Cell proliferation

Proliferation is the increase in cell number through cell division. A suitable biomaterial may support proliferation when the intended function requires tissue growth.

Cell differentiation

Differentiation is the process through which cells acquire specialized structures and functions. Chemical signals, mechanical stiffness, topography, and biochemical cues can influence cell fate.

Cell migration

Cells may move across or through a biomaterial. Pore size, connectivity, surface chemistry, and mechanical properties influence migration and tissue infiltration.

Cell death and stress

Unfavorable chemical exposure, unsuitable mechanical conditions, contamination, or degradation products can cause cellular stress or loss of viability.

Inflammation and immune response

The immune system may respond to an implanted or externally contacting material. Acute inflammation is part of the normal response to injury and implantation, while prolonged or excessive inflammation can interfere with healing and implant function.

Foreign body response

Some implanted materials trigger a foreign-body response involving immune cells, macrophages, and in certain cases fibrous tissue formation. The extent and consequences depend on material properties, implant geometry, anatomical site, and host factors.

Fibrous encapsulation

Fibrous encapsulation occurs when connective tissue forms around an implant. It may isolate a material from surrounding tissue and can be acceptable in some applications but undesirable in others, such as certain sensing or drug-delivery devices.

Blood compatibility

Definition

Hemocompatibility describes the suitability of a material for contact with blood without causing unacceptable blood-related responses.

Important interactions

  • Protein adsorption

  • Platelet adhesion and activation

  • Coagulation pathways

  • Complement activation

  • Hemolysis

  • Thrombus formation

Design implication

Materials used in blood-contacting devices require specialized evaluation because a surface that performs well in a general cell-compatibility test may still promote thrombosis or other blood-related complications.

Infection and biofilms

Microorganisms can adhere to medical-device surfaces and form biofilms, which are organized microbial communities embedded in protective extracellular material. Biofilm formation can make infections difficult to treat and can compromise implant function. Surface design, device handling, sterilization, and clinical protocols all contribute to infection prevention.

4 biocompatibility and biological evaluation

Biocompatibility is application specific

A material cannot be declared biocompatible in every possible situation based on one test. Evaluation must consider the intended anatomical location, contact type, exposure duration, patient population, and expected biological response.

Biological risk categories

  • Cytotoxicity: whether a material or its extracts cause unacceptable cellular toxicity.

  • Sensitization: whether exposure can cause an allergic-type immune response.

  • Irritation: whether contact causes an unacceptable local irritation response.

  • Systemic toxicity: whether released substances produce harmful effects beyond the local contact site.

  • Genotoxicity: whether exposure can damage genetic material.

  • Hemocompatibility: whether blood-contacting materials produce unacceptable blood-related effects.

  • Implantation response: how tissue responds to a material implanted in a particular anatomical location.

  • Degradation-related effects: whether breakdown products create harmful local or systemic responses.

Evaluation strategy

  • Define the medical purpose and intended contact conditions.

  • Identify the material composition, additives, processing residues, and possible degradation products.

  • Evaluate relevant physical and chemical characteristics.

  • Select biological tests appropriate to the device's contact type and exposure duration.

  • Interpret results using suitable controls and validated test methods.

  • Assess the combined evidence through a biological risk evaluation.

  • Continue monitoring relevant safety and performance information after clinical use when required.

In vitro testing

In vitro tests are conducted outside a living organism, commonly using cultured cells, biological fluids, or isolated biological systems. They can provide controlled information about cytotoxicity, cell behavior, and selected biological mechanisms, but they cannot reproduce every aspect of a complete living organism.

In vivo testing

In vivo studies evaluate material or device behavior in a living organism. They can provide information about tissue integration, systemic responses, and complex biological interactions. Such studies require ethical justification, appropriate oversight, and compliance with applicable regulations.

Limitations of testing

  • A single laboratory test cannot predict every clinical outcome.

  • Cell-line responses may differ from responses in primary human tissues.

  • Animal models do not perfectly reproduce human biology.

  • Material performance can change after sterilization, storage, implantation, and degradation.

  • Long-term clinical outcomes may differ from short-term laboratory observations.

5 surface properties and biological interaction

Surface chemistry

Surface chemistry determines which functional groups and chemical species are exposed to biological fluids. It influences protein adsorption, wettability, chemical stability, and cellular interactions.

Surface energy and wettability

Wettability describes how a liquid spreads across or interacts with a surface. It is commonly evaluated through contact-angle measurements. Wettability can influence protein adsorption and cell attachment, but there is no single contact angle that guarantees good biocompatibility for every application.

Surface roughness

Surface roughness describes variations in surface height at different length scales. It can influence cell attachment, bacterial adhesion, wear, and mechanical interlocking with tissue. The effect depends on the roughness scale, material, anatomical environment, and intended function.

Surface topography

Surface topography includes patterns, grooves, pores, textures, and other geometric features. It can influence the direction of cell movement, tissue integration, and local mechanical interaction.

Surface modification methods

  • Mechanical polishing and controlled texturing

  • Chemical functionalization

  • Plasma treatment

  • Thin-film and ceramic coating deposition

  • Surface grafting of polymers or biomolecules

  • Anodization of suitable metallic materials

  • Controlled introduction of porous or patterned structures

Coating design

A coating may be applied to improve corrosion resistance, reduce wear, encourage tissue interaction, provide antimicrobial functions, or control drug release. The coating must adhere reliably and remain stable under the intended mechanical and biological conditions.

Surface failure

A coating can fail through cracking, delamination, dissolution, wear, or chemical degradation. Released particles or fragments may trigger local biological responses and compromise device function.

6 mechanical properties and biomechanical compatibility

Mechanical requirements

Biomaterials must withstand the mechanical conditions of their intended anatomical environment. These conditions may include tension, compression, bending, torsion, shear, impact, friction, and repeated cyclic loading.

Elastic modulus

Elastic modulus measures stiffness within the approximately linear elastic region. A major design consideration for load-bearing implants is the difference between implant stiffness and surrounding bone stiffness.

Stress shielding

Stress shielding occurs when an implant carries a disproportionate share of the mechanical load, reducing the mechanical stimulus experienced by surrounding bone. This can contribute to bone remodeling and loss of bone density around an implant.

Fatigue

Fatigue is progressive material damage under repeated loading. Implants and devices may experience millions of loading cycles, making fatigue resistance and appropriate design essential.

Fracture toughness

Fracture toughness describes resistance to crack propagation under specified conditions. It is particularly important for brittle bioceramics and components containing defects or notches.

Wear

Wear involves material loss or surface damage due to relative motion and contact. Wear particles from joint components can cause local tissue responses and contribute to implant loosening.

Creep and stress relaxation

Some polymeric biomaterials deform gradually under sustained stress or lose stress while held at a fixed deformation. These time-dependent behaviors can affect long-term medical-device function.

Biomechanical matching

A suitable implant should provide sufficient structural support while minimizing undesirable mechanical mismatch with surrounding tissue. Matching must account for geometry, anatomical loading, material anisotropy, and biological remodeling rather than relying on elastic modulus alone.

7 biodegradable and bioresorbable materials

Definitions

Biodegradable

A biodegradable material undergoes chemical or biological breakdown through processes such as hydrolysis, enzymatic action, or oxidation.

Bioresorbable

A bioresorbable material is designed to break down and be absorbed, metabolized, or eliminated by the body through suitable biological and physiological processes.

Bioabsorbable

The term bioabsorbable is often used for materials intended to be absorbed or cleared after degradation, although exact terminology can vary across research and regulatory contexts.

Degradation mechanisms

  • Hydrolysis involves chemical bond cleavage through reaction with water.

  • Enzymatic degradation occurs through biological catalysts that act on susceptible chemical structures.

  • Oxidative degradation involves reactions with oxidizing species in the biological environment.

  • Cell-mediated degradation involves cellular activity that contributes to material breakdown or removal.

Important design parameters

  • Initial mechanical strength

  • Degradation rate

  • Molecular weight and chemical composition

  • Water uptake and permeability

  • Geometry and surface-area-to-volume ratio

  • Local pH and biological environment

  • Toxicity and clearance of degradation products

  • Rate of tissue healing or regeneration

Applications

  • Resorbable surgical sutures

  • Temporary fixation devices

  • Drug-delivery carriers

  • Tissue-engineering scaffolds

  • Selected resorbable vascular and medical-device systems

Design challenge

The material must retain adequate function during the period in which it is needed, then degrade at a rate compatible with tissue healing and safe removal of its breakdown products.

8 tissue engineering and regenerative medicine

Overview

Tissue engineering combines cells, biomaterials, biochemical signals, and suitable physical conditions to support the repair, replacement, or regeneration of tissues.

Scaffolds

A scaffold is a three-dimensional material structure designed to support cell attachment, growth, organization, and tissue formation. Its properties must be matched to the target tissue and intended regeneration process.

Scaffold design requirements

  • Suitable biocompatibility

  • Appropriate pore size and interconnectivity

  • Mechanical properties compatible with the target tissue

  • A surface that supports the intended cell-material interaction

  • Controlled degradation when a degradable scaffold is required

  • Adequate transport of nutrients, oxygen, and waste products

  • Manufacturing reproducibility and sterilization compatibility

Pore architecture

Pore size, shape, distribution, and connectivity influence cell migration, nutrient transport, vascularization, mechanical strength, and tissue formation. A highly porous scaffold may improve transport and cell infiltration but can lose mechanical strength.

Cell sources

Tissue-engineering research may use primary cells, stem cells, or other suitable cell populations. The choice depends on tissue type, biological purpose, availability, ethical considerations, and regulatory requirements.

Biochemical signals

Growth factors and other biochemical signals can influence cell survival, proliferation, migration, and differentiation. Their delivery must be controlled because excessive or poorly timed signaling may produce undesirable outcomes.

Bioreactors

Bioreactors provide controlled environments for growing or conditioning engineered tissues. They may regulate nutrient supply, oxygenation, temperature, fluid flow, and mechanical stimulation.

Vascularization challenge

Thick engineered tissues require effective transport of oxygen and nutrients. Developing functional blood-vessel networks remains a major challenge in regenerative medicine.

Current limitations

  • Complex tissues contain multiple interacting cell types and structural regions.

  • Maintaining cell viability throughout thick constructs is difficult.

  • Long-term integration with host tissue is not always predictable.

  • Manufacturing, sterilization, storage, and regulatory requirements can be challenging.

  • Clinical translation requires reproducible quality and demonstrated safety.

9 drug delivery and biomedical functional materials

Drug delivery materials

Drug-delivery biomaterials are designed to transport and release therapeutic substances in a controlled manner. They may be polymeric particles, hydrogels, porous carriers, lipid-based systems, or implantable devices.

Release mechanisms

  • Diffusion-controlled release occurs when a drug moves through a material or surrounding medium along a concentration gradient.

  • Degradation-controlled release occurs when breakdown of the carrier enables drug release.

  • Swelling-controlled release occurs when water uptake changes the structure and transport properties of a polymer network.

  • Stimuli-responsive release occurs when environmental changes such as pH, temperature, light, or specific chemical signals alter the material's behavior.

Drug delivery design factors

  • Drug stability and compatibility with the carrier

  • Initial drug loading and distribution

  • Desired release rate and duration

  • Material degradation and clearance

  • Local tissue conditions

  • Potential toxicity and immune response

  • Manufacturing reproducibility and sterilization

Biosensors

A biosensor combines a biological recognition element with a physical or chemical transducer. Biomaterials can provide the surface or matrix that immobilizes the recognition element and supports signal detection.

Smart biomedical materials

Smart biomedical materials respond to changes in their environment through reversible or controlled changes in shape, stiffness, permeability, electrical properties, or chemical activity. Applications include responsive drug delivery, tissue interfaces, and selected diagnostic systems.

10 manufacturing and processing

Overview

Biomaterial processing must produce the required geometry, microstructure, surface properties, purity, and mechanical performance while preserving biological safety and compatibility with sterilization and clinical use.

Metal processing

  • Casting and forging can produce metallic implant components with suitable shapes and mechanical properties.

  • Machining and finishing create precise dimensions and controlled surfaces.

  • Powder metallurgy and additive manufacturing can produce porous or geometrically complex structures.

  • Heat treatment can adjust microstructure and mechanical behavior, subject to alloy-specific requirements.

Ceramic processing

  • Powder synthesis and purification establish the starting material quality.

  • Powder shaping creates the required geometry.

  • Sintering densifies the ceramic through thermally activated processes.

  • Grinding and polishing establish dimensional accuracy and surface finish.

Polymer processing

  • Melt processing can produce suitable medical-grade polymer components.

  • Solution processing can form films, fibers, membranes, or porous structures.

  • Electrospinning can produce fibrous structures for selected tissue-engineering applications.

  • Hydrogel formation can create hydrated networks with controlled mechanical and transport properties.

Additive manufacturing

Additive manufacturing builds components layer by layer from digital design data. In biomaterials engineering it can produce patient-specific geometries, controlled porosity, and complex internal architectures. The resulting components still require careful evaluation of defects, surface condition, mechanical anisotropy, residual stress, and sterilization effects.

Sterilization

Purpose

Sterilization aims to eliminate viable microorganisms from a medical product to the required validated level.

Methods

  • Steam sterilization

  • Ethylene oxide sterilization

  • Gamma irradiation

  • Electron-beam irradiation

  • Selected low-temperature sterilization technologies

Material compatibility

Sterilization can affect polymer molecular weight, crosslinking, surface chemistry, color, mechanical strength, and drug stability. The appropriate method must therefore be validated for the specific material and device.

Quality assurance

Manufacturing quality assurance includes raw-material traceability, process validation, dimensional inspection, mechanical testing, surface characterization, biological evaluation, packaging integrity, and controlled documentation.

11 medical device design and regulatory requirements

Design requirements

  • Clearly defined intended medical purpose

  • Suitable mechanical and functional performance

  • Biological safety for the intended contact conditions

  • Validated manufacturing and sterilization processes

  • Acceptable degradation and wear behavior

  • Reliable packaging and storage stability

  • Usability and compatibility with clinical procedures

  • Risk management throughout the device lifecycle

Risk management

Medical-device risk management identifies hazards, estimates and evaluates risks, establishes risk controls, and monitors whether residual risks remain acceptable. Material-related hazards may include toxicity, corrosion, fracture, wear particles, infection, and degradation-product exposure.

Standards and guidance

  • ISO 10993 series for biological evaluation of medical devices

  • ISO 14971 for medical-device risk management

  • ISO 13485 for medical-device quality-management systems

  • Applicable national and regional medical-device regulations

Regulatory context

Regulatory requirements depend on the device type, intended use, risk classification, jurisdiction, and applicable standards. Material selection alone does not establish regulatory compliance; the complete device and its manufacturing system must be evaluated.

Traceability

Traceability connects raw-material batches, processing records, inspections, sterilization history, and finished devices. It is essential for quality control, investigation of failures, and appropriate clinical follow-up.

12 failure modes and long term performance

Corrosion

Corrosion is the degradation of a material through chemical or electrochemical interaction with its environment. In metallic implants it can release ions or particles and may weaken the component.

Wear and particle release

Repeated contact and movement can remove material from implant surfaces. Wear particles may trigger inflammatory responses and contribute to implant degradation.

Fatigue and fracture

Cyclic loading can initiate and propagate cracks, while brittle fracture may occur when local stress exceeds the material's resistance to crack growth.

Delamination

Coatings or composite layers may separate from their substrates when interfacial bonding is insufficient or stresses exceed the interface's resistance.

Degradation mismatch

A biodegradable scaffold or device may lose strength before tissue regeneration is sufficient, or remain too long after its intended function has ended.

Infection

Microbial contamination and biofilm formation can compromise the performance of implants and other medical devices.

Failure analysis workflow

  • Define the reported clinical or functional failure.

  • Collect device history, material specifications, and relevant manufacturing records.

  • Examine the failed component without introducing avoidable damage.

  • Characterize surface, microstructure, composition, and fracture features using suitable methods.

  • Evaluate biological, mechanical, chemical, and environmental factors.

  • Identify the most plausible failure mechanisms and distinguish evidence from speculation.

  • Recommend design, process, material, or monitoring improvements.

13 sustainability and ethical considerations

Environmental impact

Medical materials and devices can require energy-intensive processing, specialized packaging, sterilization, and complex disposal. Their environmental impacts must be considered without compromising infection control or patient safety.

Single use and reusable devices

The choice between single-use and reusable devices involves material durability, cleaning effectiveness, sterilization validation, contamination risk, lifecycle cost, and environmental impact.

Critical raw materials

Some biomedical materials depend on metals and elements with constrained supply chains. Material selection should consider availability, responsible sourcing, and opportunities for more sustainable alternatives.

Ethical considerations

  • Patient safety and informed clinical decision-making

  • Ethical oversight of animal and human research

  • Responsible use of biological materials and cells

  • Fair access to advanced medical technologies

  • Transparent reporting of material risks and device limitations

  • Environmental responsibility across manufacturing and disposal

14 advanced and emerging research

Bioactive materials

Bioactive materials are designed to produce specific interactions with biological systems, such as bonding with bone or influencing cellular responses.

Immunomodulatory materials

Research is investigating materials that influence immune-cell behavior to support healing, reduce harmful chronic inflammation, or improve tissue integration.

Organ on chip systems

Organ-on-chip platforms combine engineered materials, microfluidics, and living cells to reproduce selected functions of human tissues for research and drug evaluation.

Four dimensional bioprinting

Four-dimensional bioprinting extends three-dimensional printing by incorporating materials or structures designed to change over time in response to environmental or biological stimuli.

Patient specific implants

Medical imaging, computational design, and additive manufacturing can be combined to produce implants tailored to individual anatomical requirements.

Bioelectronic interfaces

Bioelectronic materials and devices interact with electrical signals in biological systems for sensing, stimulation, and selected therapeutic applications.

Advanced biodegradable metals

Research on magnesium-, zinc-, and iron-based systems explores temporary structural implants that gradually degrade. Controlling degradation rate, local biological response, and mechanical retention remains challenging.

Computational biomaterials

Computational modelling and data-driven methods are being used to predict material degradation, protein interactions, mechanical behavior, and biological performance. Reliable prediction still requires high-quality experimental and clinical evidence.

15 learning and investigation workflow

Learning sequence

  • Distinguish biomaterials from naturally occurring biological materials.

  • Classify metallic, ceramic, polymeric, natural, and composite biomaterials.

  • Explain biocompatibility as an application-specific concept.

  • Investigate protein adsorption, cell-material interactions, and immune responses.

  • Connect mechanical properties with the loading conditions of different tissues.

  • Compare permanent and biodegradable implant materials.

  • Study scaffold architecture and its role in tissue engineering.

  • Understand biological evaluation, sterilization, manufacturing, and medical-device risk management.

Practical design activity

Activity

Develop a conceptual material-selection plan for a bone-fixation device.

Objective

Understand how mechanical, biological, manufacturing, and regulatory requirements influence biomaterial selection.

Method

  • Define the intended anatomical location and function of the device.

  • Identify the mechanical loads and expected duration of use.

  • List relevant candidate material families, such as titanium alloys, stainless steels, and selected bioresorbable polymers.

  • Compare elastic modulus, strength, fatigue resistance, corrosion or degradation behavior, and manufacturing suitability.

  • Identify biological-contact conditions and the relevant biocompatibility evaluation needs.

  • Consider imaging compatibility, sterilization, surface condition, and clinical handling.

  • Prepare a decision matrix explaining the advantages, disadvantages, and uncertainties of each candidate.

  • State which additional laboratory and regulatory evidence would be required before any real medical application.

Expected result

A defensible material-selection report that explains trade-offs rather than declaring one material universally best.

Verification

Check whether each design requirement is linked to a measurable material or device characteristic and whether unresolved biological and engineering risks are clearly identified.

Safety and scope

This is a conceptual educational activity. It does not qualify as a clinical implant design or authorize fabrication, testing, or use in a person.

Knowledge check

  • What makes a material a biomaterial?

  • Why is biocompatibility dependent on the intended application?

  • How do metallic, ceramic, polymeric, and natural biomaterials differ?

  • Why can a highly corrosion-resistant metal still cause an undesirable biological response?

  • What is the role of protein adsorption in cell-material interactions?

  • How can implant stiffness influence surrounding bone?

  • What is the difference between biodegradable and bioresorbable materials?

  • Why are pore architecture and nutrient transport important in tissue-engineering scaffolds?

  • How can sterilization alter polymeric biomaterials?

  • Why must biological evaluation consider both the material and the complete medical device?

Variables

Sigma

Engineering stress, measured in pascals (Pa).

F

Applied axial force, measured in newtons (N).

A 0

Original cross-sectional area, measured in square metres (m^2).

Epsilon

Engineering strain, dimensionless.

Delta L

Change in specimen length, measured in metres (m).

L 0

Original specimen length, measured in metres (m).

E

Young's modulus, measured in pascals (Pa).

R

Average mass-loss rate, measured in kilograms per second (kg/s) when SI units are used.

M 0

Initial specimen mass, measured in kilograms (kg).

M t

Specimen mass at time t, measured in kilograms (kg).

T

Elapsed degradation-test time, measured in seconds (s).

Gamma SV

Solid-vapour interfacial energy, measured in joules per square metre (J/m^2).

Gamma SL

Solid-liquid interfacial energy, measured in joules per square metre (J/m^2).

Gamma LV

Liquid-vapour interfacial energy, measured in joules per square metre (J/m^2).

Theta

Equilibrium contact angle, expressed in radians or degrees.

Example or application

Title

Material selection for an orthopedic bone-fixation plate

Scenario

A bone-fixation plate is intended to stabilize a fracture while the bone heals. The material must support the required mechanical loads, resist fatigue and corrosion, remain biologically acceptable, and be compatible with manufacturing and sterilization.

Candidate materials

MaterialAdvantagesLimitations

Titanium alloy

  • Good strength-to-weight characteristics in suitable alloys

  • Good corrosion resistance

  • Generally favorable clinical experience in appropriate implant applications

  • Lower elastic modulus than many stainless steels

  • Can be more expensive than conventional stainless steel

  • Surface and wear behavior require application-specific consideration

  • Still may be stiffer than surrounding bone

Medical-grade stainless steel

  • Well-established manufacturing methods

  • Good mechanical strength

  • Often cost-effective

  • Extensive use in selected temporary orthopedic devices

  • Higher stiffness than many surrounding biological tissues

  • Corrosion and ion-release behavior require control

  • Long-term performance depends on alloy grade, surface condition, and environment

Bioresorbable polymer

  • Can gradually degrade in suitable biological environments

  • May avoid permanent retention of some temporary fixation components

  • Can be processed into selected medical-device geometries

  • Lower mechanical strength than many metallic alternatives

  • Strength decreases as degradation progresses

  • Degradation rate and products must be compatible with healing

Decision process

  • Define the expected mechanical loads and duration of fracture stabilization.

  • Determine whether permanent support or temporary support is required.

  • Compare candidate materials using strength, stiffness, fatigue, corrosion, and degradation data.

  • Assess the biological-contact conditions and relevant biological evaluation requirements.

  • Evaluate manufacturing, surface finishing, sterilization, and inspection compatibility.

  • Identify risks such as fatigue fracture, corrosion, wear, or premature degradation.

  • Select a candidate only after the full device design and its intended clinical use have been evaluated.

Conclusion

Titanium alloys, stainless steels, and bioresorbable polymers can all be useful in different fixation applications. The correct material depends on the required mechanical support, healing period, biological environment, device geometry, and clinical objectives. No candidate is automatically superior in every situation.

Definition

Biomaterials are natural or engineered materials designed to interact with biological systems for diagnostic, therapeutic, restorative, or regenerative purposes. Biomedical materials engineering applies materials science, biology, chemistry, and engineering principles to select, develop, process, characterize, and evaluate these materials so that medical devices and tissue-related systems achieve their intended functions with an acceptable biological response.

Purpose

  • Explain how materials interact with cells, tissues, blood, and other biological environments.

  • Provide scientific foundations for the design of implants, prostheses, medical devices, and regenerative systems.

  • Connect material composition, surface properties, mechanical behavior, and degradation with biological performance.

  • Introduce methods for evaluating biocompatibility, material reliability, and medical-device safety.

  • Support the development of advanced medical technologies through interdisciplinary materials engineering.

Importance

  • Biomaterials enable the replacement, repair, and support of damaged biological structures.

  • They are essential to orthopedic implants, dental devices, cardiovascular systems, wound care, and medical diagnostics.

  • Appropriate material design can improve tissue integration, device reliability, and patient outcomes.

  • Biodegradable materials can reduce the need for some secondary removal procedures when their performance and degradation are appropriately controlled.

  • Biomaterials research contributes to tissue engineering, regenerative medicine, personalized implants, and advanced drug delivery.

  • Understanding biomaterial limitations helps prevent failures related to toxicity, infection, wear, corrosion, fracture, and inappropriate host responses.

Related Topics

  • Introduction to Materials Science

  • Classification of Engineering Materials

  • Polymers and Macromolecular Materials

  • Ceramics and Inorganic Materials

  • Composites and Hybrid Materials

  • Functional and Smart Materials

  • Natural and Biological Materials

  • Materials Performance in Real-World Environments

  • Tissue Engineering

  • Biomedical Engineering

Sources and verification

Sources are shown as provided in the project data. Not every source has yet been independently verified. Please report errors or missing citations.

  • Buddy D. Ratner et al., Biomaterials Science: An Introduction to Materials in Medicine, 4th Edition.
  • Johnna S. Temenoff and Antonios G. Mikos, Biomaterials: The Intersection of Biology and Materials Science.
  • William R. Wagner and Shelly E. Sakiyama-Elbert et al., Biomaterials Science: An Introduction to Materials in Medicine, 4th Edition.
  • ISO 10993 series, Biological Evaluation of Medical Devices.
  • ISO 14971, Medical Devices — Application of Risk Management to Medical Devices.
  • National Institute of Biomedical Imaging and Bioengineering (NIBIB), biomaterials and tissue-engineering educational resources.

Suggest a correction or source · More in Materials Science